Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9594 posts found.

Ryan Smith appointed as global head of sales at Astoriom

April 29, 2025 Logistics & Distribution, Research and Development Astoriom, Pharmacy, appointment, sample storage solutions

Global R&D sample stability and biorepository storage company, Astoriom, has announced the appointment of Ryan Smith as global head of …
Appointment
europe-1395916_640

EU approval granted for rare kidney disease treatment

April 29, 2025 Market Access, Research and Development, Sales and Marketing CSL Vifor, EU, Nephrology, Travere Therapeutics, kidney disease, nephrology

The EU has granted marketing authorisation (MA) for Filspari – CSL Vifor and Travere Therapeutics’ therapy for primary IgA nephropathy …
News
stethoscope_and_background_doctor

Study finds new test could better predict risk of heart disease

April 28, 2025 Research and Development Cardiology, Chalmers University of Technologyu, Harvard, cholesterol tests, cvd

A study by Harvard University, US, and Chalmers University of Technology, Sweden, has found that measuring a lipoprotein marker combination …
News

McDavid Stilwell appointed as CFO of CPTx

April 28, 2025 Research and Development CPTx, Immunology, Oncology, appointment, cfo, therapeutics

CPTx, a German biotech company focused on single-stranded DNA therapeutics, has announced the appointment of McDavid Stilwell as chief financial …
Appointment
clinical_trials

Successful clinical outcomes for drug treating rare stroke condition

April 25, 2025 Research and Development Bioxodes, Neurology, clinical trial, stroke

Flemish biopharma company, Bioxodes, has announced promising results from the BIRCH phase 2a clinical trial of BIOX-101 to treat intracerebral …
News
trialy

Mosaic Therapeutics in-licenses clinical oncology programmes from Astex Pharma

April 25, 2025 Clinical Trial Services, Industry Associations, Mergers and Acquisitions, Research and Development Astex pharmaceuticals, Mosaic Therapeutics, Oncology, clinical trial

Two clinical-stage oncology programmes from Astex Pharmaceuticals have been announced by Mosaic Therapeutics, allowing it to develop targeted oncology drug …
News

Philippe Masset appointed to Vect-Horus board of directors

April 25, 2025 Research and Development Oncology, Vect-Horus, appointment, board of directors, imaging agents

Vect-Horus has announced the appointment of Philippe Masset to the company’s board of directors. This contributes to a series of …
Appointment
blood_tests_pic

Mursla Bio’s platform for surveillance of liver cancer receives FDA approval

April 24, 2025 Industry Associations, Research and Development BDD, FDA, Mursla Bio, Oncology, hepatocellular carcinoma (HCC), liver disease

The US Food and Drug Administration (FDA) has granted Breakthrough Device Designation (BDD) to EvoLiver, Mursla Bio’s surveillance platform for …
News

Hansa Biopharma appoints Renée Aguiar-Lucander as CEO

April 24, 2025 Research and Development CEO, Corporate, Hansa Biopharma, appointment, immunology

Swedish biopharma company, Hansa Biopharma, has announced the appointment of new chief executive officer (CEO) Renée Aguiar-Lucander, replacing Søren Tulstrup …
Appointment

ViroCell and UCL launch trial to treat childhood leukaemia relapse

April 24, 2025 Research and Development Oncology, UCL, ViroCell, acute lymphoblastic leukaemia, cell therapy, clinical trial, leukaemia

ViroCell Biologics has manufactured a GMP-grade lentiviral vector for a University College London (UCL) clinical trial aimed at tackling relapse …
News

Dual immunotherapy for bowel cancer now available under NHS

April 23, 2025 Research and Development Bristol Myer Squibb, MHRA, NICE, Oncology, bowel cancer, colorectal cancer, immunotherapy

Dual immunotherapy, a combination of Opdivo (nivolumab) and Yervoy (ipilimumab), has been granted extension in the UK by the Medicines …
News
handshake_2

AOTI diabetic foot care therapy to be used by NHS

April 23, 2025 Research and Development AOTI, Diabetes, diabetes, diabetic foot care, health economic study

Effective from September 2025, AOTI’s Topical Wound Oxygen (TWO2) therapy has been awarded inclusion in the NHS supply chain. It …
News

Galapagos announces leadership changes amid planned company split

April 22, 2025 Analytical & Laboratory Services, Research and Development CEO Appointment, Corporate, Galapagos, cell therapy

Galapagos NV has announced key leadership changes as it prepares to separate into two independent entities. Henry Gosebruch has been …
Appointment

Allegro confirms successful safety testing of osteoarthritis treatment

April 17, 2025 Research and Development Allegro, Osteoporosis, joint disease, oesteoarthritis, pretrial

Allegro’s hydrocelin treatment for osteoarthritis has demonstrated a satisfactory safety profile, giving it potential to become a leading disease-modifying treatment …
News
blood_test

Johnson & Johnson announces successful results from trial for myeloma treatment

April 16, 2025 Research and Development Johnson & Johnson, Oncology, myeloma, pharma, trial

Global healthcare company, Johnson & Johnson, announced that analysis of its Darzalex (daratumumab) therapy showed significantly longer progression-free survival (PFS) …
News
The Gateway to Local Adoption Series

Latest content

BMS’ Opdivo/Yervoy combination accepted by Scottish Medicines Consortium for colorectal cancer

February 5, 2026

AstronauTx appoints Adam Rosenberg as Chair of the Board

February 5, 2026

Astellas Pharma’s Vyloy accepted by Scottish Medicines Consortium for gastric cancer

February 4, 2026

Angelini Pharma appoints Sergio Marullo di Condojanni as CEO

February 4, 2026

QV Bioelectronics secures £4.5m in funding for brain cancer therapy development

February 3, 2026